GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.377
-0.007 (-1.69%)
At close: Dec 5, 2025, 4:00 PM EST
0.380
+0.003 (0.80%)
After-hours: Dec 5, 2025, 7:57 PM EST
GeoVax Labs Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 3.35 | 3.95 | - | 0.08 | 0.39 | 1.82 | |
| Revenue Growth (YoY) | 8.52% | - | - | -78.85% | -78.86% | 55.09% | |
| Cost of Revenue | 22.74 | 23.71 | 20.72 | 9.12 | 15.55 | 2.44 | |
| Gross Profit | -19.38 | -19.76 | -20.72 | -9.04 | -15.17 | -0.62 | |
| Selling, General & Admin | 6.16 | 5.39 | 6.02 | 4.99 | 3.58 | 2.2 | |
| Operating Expenses | 6.16 | 5.39 | 6.02 | 4.99 | 3.58 | 2.2 | |
| Operating Income | -25.54 | -25.14 | -26.74 | -14.03 | -18.75 | -2.82 | |
| Interest Expense | - | -0.02 | - | - | -0 | -0.14 | |
| Interest & Investment Income | 0.23 | 0.17 | 0.78 | 0.01 | 0 | 0 | |
| EBT Excluding Unusual Items | -25.31 | -24.99 | -25.97 | -14.02 | -18.74 | -2.96 | |
| Other Unusual Items | - | - | - | - | 0.17 | - | |
| Pretax Income | -25.31 | -24.99 | -25.97 | -14.02 | -18.57 | -2.96 | |
| Net Income | -25.31 | -24.99 | -25.97 | -14.02 | -18.57 | -2.96 | |
| Net Income to Common | -25.31 | -24.99 | -25.97 | -14.02 | -18.57 | -2.96 | |
| Shares Outstanding (Basic) | 16 | 5 | 2 | 1 | 0 | 0 | |
| Shares Outstanding (Diluted) | 16 | 5 | 2 | 1 | 0 | 0 | |
| Shares Change (YoY) | 374.84% | 185.43% | 60.60% | 178.25% | 340.80% | - | |
| EPS (Basic) | -1.63 | -4.82 | -14.29 | -12.39 | -45.67 | -32.06 | |
| EPS (Diluted) | -1.63 | -4.82 | -14.29 | -12.39 | -45.67 | -32.06 | |
| Free Cash Flow | -24.29 | -24.7 | -25.22 | -19.16 | -11.24 | -2.91 | |
| Free Cash Flow Per Share | -1.56 | -4.76 | -13.88 | -16.94 | -27.65 | -31.51 | |
| Gross Margin | - | - | - | - | - | -34.04% | |
| Operating Margin | -761.63% | -635.83% | - | -17207.47% | -4862.72% | -154.46% | |
| Profit Margin | -754.69% | -631.98% | - | -17198.35% | -4817.19% | -162.21% | |
| Free Cash Flow Margin | -724.40% | -624.50% | - | -23507.18% | -2916.76% | -159.42% | |
| EBITDA | -25.47 | -25.05 | -26.67 | -13.97 | -18.71 | -2.8 | |
| EBITDA Margin | - | - | - | - | - | -153.38% | |
| D&A For EBITDA | 0.07 | 0.1 | 0.07 | 0.06 | 0.04 | 0.02 | |
| EBIT | -25.54 | -25.14 | -26.74 | -14.03 | -18.75 | -2.82 | |
| EBIT Margin | - | - | - | - | - | -154.46% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.